
Granules India Ltd. (GRANULES) 52 Week High Streak: Second Straight Session
Updated: 15 Sept 2026 • 9:28 am
Posted by:

Granules India 52 Week High Streak: Granules India Ltd. has now set a fresh 52-week high for its second straight session, with the streak advancing 1.31% across the two-day run to a latest peak of Rs 922.1 while last traded at Rs 913.35. The latest Univest figures confirm the repeated-high pattern, but they do not establish a company-specific catalyst for the continued move.
As of 15 September 2026 at 9:22 AM IST, the stock was trading above the previous close of Rs 909.65 after opening at Rs 915.2 and touching a low of Rs 909.05. Turnover stood at Rs 1.31 crore and market capitalisation at Rs 22,540.85 crore. For readers tracking Granules India Share Price Today, the key point is not just the day’s move, but the fact that the stock is printing a new one-year high again within the same streak.
Granules India Ltd. 52 Week High Streak: Consecutive High Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 913.35 |
| Previous Close | Rs 909.65 |
| Today's Move | +Rs 3.7 (+0.41%) |
| Open | Rs 915.2 |
| High | Rs 922.1 |
| Low | Rs 909.05 |
| Turnover | Rs 1.31 crore |
| Market Capitalisation | Rs 22,540.85 crore |
Granules India Ltd. (GRANULES) traded at Rs 913.35 versus the previous close of Rs 909.65, a rise of 0.41%. The stock opened at Rs 915.2, reached a high of Rs 922.1 and touched a low of Rs 909.05.
Granules India’s share price was at Rs 913.35, up Rs 3.7 or 0.41% from the previous close of Rs 909.65. The stock opened at Rs 915.2, moved between Rs 909.05 and Rs 922.1, and last traded near the upper end of that range. The 52-week high of Rs 922.1 is now the latest reference point for the market, while turnover of Rs 1.31 crore and market capitalisation of Rs 22,540.85 crore place the move in a clear stock-specific context.
For investors scanning Granules India Stock News and Granules India Share Price Update, the more relevant detail is the repeated high rather than the single-day change. The stock has already registered a fresh one-year high on two consecutive sessions, which makes this a streak event rather than an isolated breakout. That distinction matters because the market is no longer reacting to one print alone; it is repeatedly allowing the stock to reset its one-year peak.
What the Repeated 52-Week Highs Show
Granules India 52 Week High Streak: the repeat high pattern shows that the stock has continued to trade at fresh one-year peaks for its second straight session, with a cumulative gain of 1.31% across the streak. The latest high of Rs 922.1 is only above the current traded price by a narrow gap, which keeps attention on how the stock behaves around that level during the current market update.
What can be said confidently is that the price action confirms persistence across sessions. What cannot be concluded from the numbers alone is why the pattern is extending. The latest Univest data does not identify a company-specific trigger, so any discussion of cause should stay disciplined and factual. For search intent around Granules India New One Year High, Granules India Back to Back 52 Week Highs and Stocks Hitting 52 Week Highs, this streak is notable because it turns a single breakout into a repeated market event.
That makes the current stage more useful for monitoring than for speculation. Investors watching Granules India Stock Performance may focus on whether the repeated high continues to hold in subsequent trading, but the present reading only confirms the pattern itself. It does not establish a narrative beyond the observed prices.
Granules India Ltd. (GRANULES) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 22,540.85 crore |
| P/E Ratio | 34.03x |
| P/B Ratio | 4.6x |
| ROE | 14.13% |
| ROCE | 15.74% |
| EPS | Rs 26.73 |
| Book Value Per Share | Rs 197.72 |
| Dividend Yield | 0.19% |
Granules India Ltd. (GRANULES) fundamental metrics show P/E 34.03x, P/B 4.6x, ROE 14.13%, ROCE 15.74%. These figures provide context only and are not a buy or sell signal.
Granules India Ltd. has a market capitalisation of Rs 22540.85 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 34.03x, P/B at 4.6x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 14.13% and ROCE of 15.74%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 26.73, book value per share of Rs 197.72, dividend yield of 0.19%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.41x, median ROE of 11.61%, median ROCE of 13.18%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 34.03x |
| Benchmark Median P/E | 32.41x |
| Benchmark Average P/E | 49.24x |
| Benchmark P/E Range | 3.34x to 693.7x |
| Company P/B Ratio | 4.6x |
| Benchmark Median P/B | 3.04x |
| Company ROE | 14.13% |
| Benchmark Median ROE | 11.61% |
| Company ROCE | 15.74% |
| Benchmark Median ROCE | 13.18% |
| Company Market Capitalisation | Rs 22,540.85 crore |
| Benchmark Median Market Cap | Rs 692.38 crore |
Granules India Ltd. (GRANULES) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Granules India Ltd. (GRANULES) has a P/E ratio of 34.03x, which is above the benchmark median of 32.41x, a difference of +5%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Granules India Ltd. (GRANULES) has a ROE of 14.13%, which is above the benchmark median of 11.61%, a difference of +21.71%. Granules India Ltd. (GRANULES) has a ROCE of 15.74%, which is above the benchmark median of 13.18%, a difference of +19.42%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Caplin Point Laboratories Ltd. | CAPLIPOINT | 20,939.32 | 31.47 | 5.7 | 20.79 | 24.97 |
| Shilpa Medicare Ltd. | SHILPAMED | 18,812.04 | 63.27 | 7 | 9.82 | 11.43 |
| Eris Lifesciences Ltd. | ERIS | 18,805.75 | 29.21 | 4.66 | 19.23 | 14.47 |
| Pfizer Ltd. | PFIZER | 18,582.96 | 25.28 | 4.22 | 17.16 | 23.39 |
| AMI Organics Ltd. | ACUTAAS | 27,650.74 | 71.59 | 16.03 | 24.08 | 32.42 |
Granules India Ltd. (GRANULES) has a P/E ratio of 34.03x compared with the displayed peer median of 31.47x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 14.13% compares with a peer median of 19.23% across the companies shown in the table. ROCE stood at 15.74% versus the displayed peer median of 23.39%, providing a capital-efficiency comparison. Granules India Ltd. (GRANULES) has a market capitalisation of Rs 22,540.85 crore. Among the 5 peers shown, 1 has a larger market capitalisation.
Why Investors Are Watching Granules India
- Granules India has set a fresh 52-week high for a second straight session.
- The cumulative streak move stands at 1.31% across the consecutive high run.
- The latest high of Rs 922.1 is the current one-year peak to watch.
- The stock’s P/E of 34.03 and P/B of 4.6 keep valuation in focus.
- ROE of 14.13% and ROCE of 15.74% provide operating context for the move.
About Granules India Ltd.
Granules India Ltd. is a pharmaceutical company in the Healthcare sector, operating within the Pharmaceuticals & Drugs industry. The company is tracked on NSE and BSE and is often followed for its stock performance, market capitalisation and valuation metrics. With a market cap of Rs 22,540.85 crore, it sits among the more closely watched names in its peer set.
For readers using Granules India Share Price and Granules India Stock Analysis as search entry points, the company’s current streak gives a clean market signal to monitor alongside its fundamentals. EPS, book value, ROE and ROCE remain useful reference points as the stock continues to trade near a fresh one-year peak.
Track Granules India on Univest
Track Granules India Ltd. on Univest to follow the latest share price, stock news, market capitalisation and company updates in one place. The stock’s repeated 52-week high pattern makes it a name worth keeping on a watchlist during the current market update.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why is Granules India still hitting 52-week highs?
Ans. The latest Univest figures confirm that Granules India has printed a fresh 52-week high for a second straight session. The numbers show the pattern clearly, but they do not establish a company-specific catalyst behind the repeated highs.
How many sessions has Granules India set a fresh one-year high?
Ans. Granules India has set a fresh one-year high for two consecutive trading sessions. That makes this an extended streak rather than a one-day breakout, which is why the move is being tracked separately.
What is the cumulative move across the Granules India 52 week high streak?
Ans. The cumulative streak gain is 1.31%. This figure covers the full consecutive run of fresh highs and is more relevant than the single-session change for understanding the current price pattern.
What is the latest 52-week high for Granules India?
Ans. The latest 52-week high is Rs 922.1. The stock traded just below that level at Rs 913.35, which keeps the one-year peak as the key reference point for readers following the streak.
Is Granules India’s valuation expensive compared with peers?
Ans. Granules India’s P/E of 34.03 is slightly above the industry median of 32.41, while its P/B of 4.6 is above the median of 3.04. That points to a firm but not extreme valuation versus the peer set.
What do Granules India’s ROE and ROCE suggest?
Ans. ROE stands at 14.13% and ROCE at 15.74%, both above the industry medians. That provides a useful operating backdrop for the stock, even though valuation still needs to be judged carefully.
How does Granules India compare with pharmaceutical peers?
Ans. Granules India sits in a middle valuation band versus peers such as Caplin Point, Eris Lifesciences and Pfizer, while some names like Shilpa Medicare, AMI Organics and Neuland Laboratories trade at much richer multiples.
What should investors monitor next in Granules India?
Ans. Investors can monitor whether the stock keeps printing fresh highs in coming sessions, how it trades around Rs 922.1, and whether the current valuation remains supported by sector context and operating ratios.
Track Granules India Ltd. (GRANULES) Share Price on Univest
Use Granules India Ltd. (GRANULES) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Recent Articles

Bank Of Maharashtra (MAHABANK) Share Price Touches Fresh 52-Week High of Rs 94.70, Up 2.93%
17 November 2026

Silver Price Crash Explained on 17 November 2026: Why MCX Silver Fell From a Rs 4.20 Lakh Record to About Rs 1.69 Lakh Per Kg, Nearly 60% Lower, as US Inflation, a Strong Dollar and Weak Industrial Demand Weigh
17 November 2026

Northern Coalfields IPO and Central Coalfields IPO Plans: Coal India Begins Preparations for 2027 Listings of About a 10% Stake Each, With Bankers in Early Talks and a 2030 Target to List All Subsidiaries
17 November 2026

PNB vs Canara Bank on 17 November 2026: Punjab National Bank Trades at Rs 149.96 and Canara Bank at Rs 135.68 as Nifty PSU Bank Gains 2.19%, Compared on Valuation, Q2 Profit, Asset Quality and Growth
17 November 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Bank Of Maharashtra (MAHABANK) Share Price Touches Fresh 52-Week High of Rs 94.70, Up 2.93%
Silver Price Crash Explained on 17 November 2026: Why MCX Silver Fell From a Rs 4.20 Lakh Record to About Rs 1.69 Lakh Per Kg, Nearly 60% Lower, as US Inflation, a Strong Dollar and Weak Industrial Demand Weigh
Northern Coalfields IPO and Central Coalfields IPO Plans: Coal India Begins Preparations for 2027 Listings of About a 10% Stake Each, With Bankers in Early Talks and a 2030 Target to List All Subsidiaries
PNB vs Canara Bank on 17 November 2026: Punjab National Bank Trades at Rs 149.96 and Canara Bank at Rs 135.68 as Nifty PSU Bank Gains 2.19%, Compared on Valuation, Q2 Profit, Asset Quality and Growth
FirstCry Share Price Surges Up to 12.7% on 17 November 2026 as Brainbees Solutions Cuts Its Q2 FY27 Net Loss by 75% to Rs 12.6 Crore on 14% Revenue Growth, While Margins and Lower ESOP Costs Draw Scrutiny
Popular this week
Kotak Mahindra Bank (KOTAKBANK) 52 Week High Streak: Fresh Peak for Second Straight Session

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





